The Stanley J. Korsmeyer Award recognizes the outstanding achievements of ASCI members in advancing knowledge in a specific field and in mentoring future generations of life science researchers. The recognition, which was first known as the ASCI Award, was renamed in 2006 in honor of Dr. Stanley J. Korsmeyer, a dedicated and accomplished physician-scientist and mentor who was the first recipient in 1998 and who passed away in 2005. The recipient of the annual Award is provided with a $20,000 honorarium and presents the Korsmeyer Lecture at the Society’s annual meeting.
Award Recipients
Nicole Calakos, MD, PhD
For her contributions to understanding basal ganglia physiology and its involvement in diseases such as compulsive behavior and movement disorders.
Peter Tontonoz, MD, PhD
For his contributions to the understanding of the regulatory pathways of lipid metabolism and their effect on normal physiology and metabolic disease.
Benjamin L. Ebert, MD, PhD
For his contributions to the understanding of the genetics, biology, and treatment of myeloid malignancies.
Judith A. James, MD, PhD
For her contributions to understanding the mechanisms of systemic autoimmune diseases.
Michael S. Diamond, MD, PhD
For his key contributions to understanding the molecular basis of disease caused by globally emerging RNA viruses.
Joseph Heitman, MD, PhD
For his key contributions to our understanding of how eukaryotic microbial pathogens evolve, cause disease, and develop drug resistance; and his discovery of TOR and FKBP12 as targets of the immunosuppressive chemotherapeutic drug rapamycin.
James E. Crowe Jr., MD
For his research leading to the development of innovative technologies for the isolation and study of antiviral antibodies and for significantly advancing the fields of virology and immunology.
Jean-Laurent Casanova, MD, PhD
For his discovery that single-gene inborn errors of immunity can underlie life-threatening infectious diseases in otherwise healthy children and young adults.
Louis J. Ptáček, MD
For research leading to the development of the field of ion channel defects, known commonly as channelopathies.
Beth Levine, MD
In recognition of fundamental contributions to our understanding of autophagy.
Bruce Beutler, MD
In recognition of his contributions to the field of innate immunity.
William G. Kaelin, Jr., MD, and Gregg L. Semenza, MD, PhD
In recognition of their contributions to the molecular understanding of cellular oxygen sensing and cellular adaptation to hypoxia.
Brian J. Druker, MD, and Charles L. Sawyers, MD
In recognition of their contributions to the development of novel therapeutics in the treatment of leukemia and other forms of cancer.
Andrew R. Marks, MD
In recognition of his discoveries that rapamycin inhibits coronary artery stent restenosis, and the role of leaky ryanodine receptor/calcium release channels in heart failure, cardiac arrhythmias and muscular dystrophy.
Mitchell A. Lazar, MD, PhD
For his outstanding contributions to our understanding of the transcriptional regulation of metabolism.
Gerald I. Shulman, MD, PhD
For his contributions to furthering our understanding of the mechanisms underlying the pathogenesis of type 2 diabetes.
D. Gary Gilliland, MD, PhD
For his contributions to the understanding of the genetic basis of human hematological malignancies.
Shaun Robert Coughlin, MD, PhD
For his outstanding contributions in the field of signal transduction via thrombin receptors.
Francis S. Collins, MD, PhD
For his pioneering efforts in the development of the entire field of human genome research.
David Ginsburg, MD
For his contributions to the understanding of the molecular basis of physiologic and pathologic thrombosis and hemostasis.
Craig B. Thompson, MD
For his discovery of the critical role costimulatory receptors play in regulating immune responses.
Ronald A. DePinho, MD
For fundamental discoveries in cancer research, aging, and chronic degenerative disease.
Laurie H. Glimcher, MD
For seminal contributions to our understanding of the transcriptional regulation of lymphocyte subset differentiation.
Christine Edry Seidman, MD
For employing molecular genetic approaches in defining the etiology of inherited human disorders and genetic engineering to produce murine models of human disease, with particular emphasis on heart disease.
Richard D. Klausner, MD
For the discovery of key mechanisms that regulate metal metabolism and intracellular trafficking.
Stanley J. Korsmeyer, MD
For the identification of key genetic mechanisms that govern cell death and survival.